Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank80
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P80
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-5114.50%
Historical baseline
PeriodValueYoY Change
20250.00%+100.0%
2024-25837.05%-30364.2%
2023-84.81%+92.9%
2022-1189.84%+66.7%
2021-3575.27%-
20200.00%-